Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cell and Stem Cell(Electronic Edition) ›› 2017, Vol. 07 ›› Issue (02): 124-128. doi: 10.3877/cma.j.issn.2095-1221.2017.02.011

Special Issue:

• Review • Previous Articles    

Advances in research of induced differentiation of mesenchymal stem cells into alveolar epithelial cells for treatment of ARDS

Qingui Chen1, Mian Zeng1,()   

  1. 1. Medical Intensive Care Unit, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2017-01-10 Online:2017-04-01 Published:2017-04-01
  • Contact: Mian Zeng
  • About author:
    Corresponding author: Zeng Mian, Email:

Abstract:

Acute respiratory distress syndrome (ARDS) , which is notorious for its high mortality rate, is one of the greatest challenges in the field of respiratory and critical care medicine. Mesenchymal stem cell (MSC) , which is readily available and easily expandablein vitro, is considered to be a promising therapy for ARDS. Numerous studies have shown the effectiveness of MSC in the treatment of ARDS. Although the mechanism is not completely understood, differentiation of MSC into alveolar epithelial cells to repair injured lung tissue may be one of the possible mechanisms. Herein, research progress of induced differentiation of MSC into alveolar epithelial cells and its application in the treatment of ARDS is reviewed.

Key words: Mesenchymal stem cells, Pulmonary alveoli, Epithelial cells, Acute disease, Respiratory distress syndrome

京ICP 备07035254号-3
Copyright © Chinese Journal of Cell and Stem Cell(Electronic Edition), All Rights Reserved.
Tel: 0086-591-87982783 E-mail: ccsct@vip.163.com
Powered by Beijing Magtech Co. Ltd